Exosens SAS (EXENS)

Currency in EUR
38.30
-0.70(-1.79%)
Real-time Data·

EXENS Financial Summary

Key Ratios

P/E Ratio36.22
Price/Book4.69
Debt / Equity62.5%
Return on Equity13.73%
Dividend Yield0.24%
EBITDA94.40M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of EUR (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.10%
Dividend Yield
0.26%
Industry Median 1.18%
Annualised payout
0.10
Paid annually
5-Years Growth
-
Growth Streak

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 42.57
(+11.15% Upside)

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
0.27 / --
Revenue / Forecast
112.26M / 119.50M
EPS Revisions
Last 90 days

FAQ

What were Exosens's earnings for the latest quarter?

The Exosens EPS (TTM) is 1.10. Exosens reported sales of 112.26, net income of 13.95, and EPS of 0.27 for the latest quarter.

What was Exosens's net income for the latest quarter?

Exosens's net income for the latest quarter was 13.95.

How did Exosens's performance compare year-over-year in the latest quarter?

The company's revenue moved from 112.26 in the previous quarter to 112.26 in the latest quarter, and net income moved from 13.95 to 13.95 compared to the previous quarter.

What is Exosens's net profit margin on a TTM basis?

Exosens's trailing twelve months (TTM) net profit margin is 7.79%.

How does Exosens's debt to equity ratio compare to industry standards?

Exosens's total debt-to-equity ratio is 62.50%.

What is Exosens's return on investment on a TTM basis?

Exosens's trailing twelve months (TTM) return on investment (ROI) is 13.73%.

Did Exosens gain or lose cash last quarter?

In the latest quarter, Exosens's net change in cash was -13.40 million.

What were Exosens's total assets and liabilities in the latest quarter?

As of the latest quarter, Exosens reported total assets of 867.32 million and total liabilities of 124.78 million.

How has Exosens's total revenue grown this year?

Exosens's total revenue was 112.26 in the previous quarter and 112.26 in the latest quarter.

What is Exosens's gross margin on a TTM basis?

Exosens's trailing twelve months (TTM) gross margin is 59.92%.

What was Exosens's revenue per share for the latest quarter?

Exosens's revenue per share for the latest quarter was 83.02.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.